2.11 (-%)
As of Oct 18, 2024
Source:
Orgenesis Inc is a global biotech company working to unlock the potential of CGTs in an affordable and accessible format. CGTs can be centered onautologous (using the patient’s own cells) or allogenic (using master banked donor cells) and are part of a class of medicinesreferred to as advanced therapy medicinal products, or ATMPs.
| Country | United States |
| Headquarters | germantown, maryland |
| Phone Number | (480) 659-6404 |
| Industry | manufacturing |
| CEO | Vered Caplan |
| Website | orgenesis.com |